Page 83 - ITPS-7-2

INNOSC Theranostics and
Pharmacological Sciences Youth brain health check and dysregulation

conferences of the international society of Addiction 248. Bagley SM, Schoenberger SF, dellaBitta V, et al. Ambivalence and
medicine. Drug Alcohol Depend. 2023;245:109805. stigma beliefs about medication treatment among young adults
with opioid use disorder: A qualitative exploration of young
doi: 10.1016/j.drugalcdep.2023.109805
adults’ perspectives. J Adolesc Health. 2023;72(1):105-110.
238. Ellis JD, Rabinowitz JA, Ware OD, Wells J, Dunn KE, doi: 10.1016/j.jadohealth.2022.08.026
Huhn AS. Patterns of polysubstance use and clinical
comorbidity among persons seeking substance use 249. Singh N, Varshney U. Adaptive interventions for opioid
treatment: An observational study. J Subst Use Addict Treat. prescription management and consumption monitoring.
2023;146:208932. J Am Med Inform Assoc. 2023;30(3):511-528.
doi: 10.1016/j.josat.2022.208932 doi: 10.1093/jamia/ocac253
239. Lake S, Buxton J, Walsh Z, et al. Methadone dose, Cannabis 250. Santino F, Gentilucci L. Design of κ-opioid receptor
use, and treatment retention: Findings from a community- agonists for the development of potential treatments of
based sample of people who use unregulated drugs. J Addict pain with reduced side effects. Molecules. 2023;28(1):346.
Med. 2023;17(1):e18-e26. doi: 10.3390/molecules28010346
doi: 10.1097/ADM.0000000000001032 251. Hendricks MA, El Ibrahimi S, Ritter GA, et al. Association
240. Hickey TR, Henry JT, Edens EL, Gordon AJ, Acampora G. of household opioid availability with opioid overdose.
Perioperative management of extended-release JAMA Netw Open. 2023;6(3):e233385.
buprenorphine. J Addict Med. 2023;17(1):e67-e71. doi: 10.1001/jamanetworkopen.2023.3385
doi: 10.1097/ADM.0000000000001024 252. Laks J, Walley AY, Bagley SM, et al. Developing a women’s
health track within addiction medicine fellowship:
241. Aslan M, Sala M, Gueorguieva R, Garrison KA.
A network analysis of cigarette craving. Nicotine Tob Res. Reflections and inspirations. Addict Sci Clin Pract.
2023;25(6):1155-1163. 2023;18(1):3.
doi: 10.1186/s13722-022-00357-8
doi: 10.1093/ntr/ntad021
253. Mestre-Bach G, Potenza MN. Potential biological markers
242. Bonnet U, Kanti AK, Scherbaum N, Specka M. The role
of gabapentinoids in the substance use pattern of adult and treatment implications for binge eating disorder and
Germans seeking inpatient detoxification treatment - A behavioral addictions. Nutrients. 2023;15(4):827.
pilot study. J Psychoactive Drugs. 2023;55(1):102-111. doi: 10.3390/nu15040827
doi: 10.1080/02791072.2022.2050858 254. Dydyk AM, Sizemore DC, Trachsel LA, Conermann T,
Porter BR. Vermont controlled substance abuse, diversion,
243. Novet B, Simon O, Bonjour S, et al. Addiction: What’s new storage, disposal, monitoring, and legal issues. In:
in 2022. Rev Med Suisse. 2023;19(N 809-10):12-15.
StatPearls. Treasure Island, FL: StatPearls Publishing; 2022.
doi: 10.53738/REVMED.2023.19.809-10.12
255. Sussman S, Sinclair DL. Treating behavioural addictions
244. Yue Y, Zou L, Li H, et al. Therapeutic effect of implanted and that lack diagnostic criteria. Nature. 2023;613(7942):27.
non-invasive vagus nerve stimulation on heroin-induced doi: 10.1038/d41586-022-04567-7
anxiety. Biochem Biophys Res Commun. 2023;652:46-54.
256. Elbau IG, Lynch CJ, Downar J, et al. Functional connectivity
doi: 10.1016/j.bbrc.2023.02.041 mapping for rTMS target selection in depression. Am J
245. Wunsch C, Wightman R, Pratty C, et al. Thirty-day Psychiatry. 2023;180(3):230-240.
treatment continuation after audio-only buprenorphine doi: 10.1176/appi.ajp.20220306
telehealth initiation. J Addict Med. 2023;17(2):206-209.
257. Mergelsberg ELP, de Ruijter D, Crone MR, Smit ES,
doi: 10.1097/ADM.0000000000001077 Hoving C. Active ingredients of interventions improving
246. Basheer M, Hassan Z, Gam LH. Upregulation of brain’s smoking cessation support by dutch primary care providers:
calcium binding proteins in mitragynine dependence: A systematic review. Eval Health Prof. 2023;46(1):3-22.
A potential cellular mechanism to addiction. Int J Med Sci. doi: 10.1177/01632787221099941
2023;20(1):102-113.
258. Zhang W, Pu J, He R, et al. Demographic characteristics,
doi: 10.7150/ijms.78861 family environment and psychosocial factors affecting
247. Bach P, de Timary P, Gründer G, Cumming P. molecular internet addiction in Chinese adolescents. J Affect Disord.
imaging studies of alcohol use disorder. Curr Top Behav 2022;315:130-138.
Neurosci. 2023;1:1-31. doi: 10.1016/j.jad.2022.07.053
doi: 10.1007/7854_2022_414 259. Guinchat V, Baeza-Velasco C, Bulbena A, Castori M.

Volume 7 Issue 2 (2024) 23 doi: 10.36922/itps.1472